monoclonal antibodies

Abelacimab, an experimental anti-clotting drug, was effective at lowering bleeding in people with atrial fibrillation (A-Fib) who were at risk of having a stroke compared with a competing drug, according...

Paxlovid didn’t help older adults with long COVID, study shows … What geriatricians should know about monoclonal anti-amyloid antibodies for Alzheimer’s … High salt linked to type 2 diabetes...

Even though newer monoclonal antibodies are available for Alzheimer’s disease, there are limits on the number of older adults who can receive them, a recent study published in Neurology finds.

Feds make deal with Regeneron on more COVID-19 monoclonal antibodies … These “secrets” help people in blue zones live longer … What it’ll take to make Alzheimer’s blood tests routine … Study...

HHS reaches agreement with drugmaker on next generation of COVID treatments favored by nursing homes … Take blood pressure readings while patient lies down for better risk prediction: AHA … Encouraging...

Even though oral antiviral drugs and monoclonal antibodies help people recover from COVID-19, a new report found that nursing homes didn’t use the medications much during the pandemic.  

Trial results for AstraZeneca’s experimental antibody, a potential replacement for Evusheld, could be out by September. The company is hoping for emergency use authorization by the end of 2023.

New data on Lilly’s experimental drug donanemab may influence CMS’s restrictive stance on coverage of this and other amyloid-busting Alzheimer’s treatments, a company executive says.

For two years, monoclonal antibodies were approved, revoked and sometimes reauthorized or scarce, but pushing through these challenges “unequivocally saved lives and prevented hospitalizations,”...

Health and Human Services Secretary Xavier Becerra came under fire Wednesday during a Senate Finance Committee meeting regarding the Centers for Medicare & Medicaid Services’ restrictive national...